1 reports of this reaction
16.7% of all METHYL SALICYLATE, MENTHOL reports
#6 most reported adverse reaction
REFUSAL OF TREATMENT BY PATIENT is the #6 most commonly reported adverse reaction for METHYL SALICYLATE, MENTHOL, manufactured by Accord Healthcare, Inc.. There are 1 FDA adverse event reports linking METHYL SALICYLATE, MENTHOL to REFUSAL OF TREATMENT BY PATIENT. This represents approximately 16.7% of all 6 adverse event reports for this drug.
Patients taking METHYL SALICYLATE, MENTHOL who experience refusal of treatment by patient should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
REFUSAL OF TREATMENT BY PATIENT is a frequently reported adverse event for METHYL SALICYLATE, MENTHOL, accounting for a significant proportion of all reports.
In addition to refusal of treatment by patient, the following adverse reactions have been reported for METHYL SALICYLATE, MENTHOL:
REFUSAL OF TREATMENT BY PATIENT has been reported as an adverse event in 1 FDA reports for METHYL SALICYLATE, MENTHOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
REFUSAL OF TREATMENT BY PATIENT accounts for approximately 16.7% of all adverse event reports for METHYL SALICYLATE, MENTHOL, making it a notable side effect.
If you experience refusal of treatment by patient while taking METHYL SALICYLATE, MENTHOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.